Catalyst Wire Dossier Catalyst Wire Dossier

CAIV-T (liquid formulation of influenza virus vaccine)

not specified · MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAIV-T (liquid formulation of influenza virus vaccine), covering 2021-09-13 to 2021-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older [Phase 2]

See pricing